|
 In what it called a major expansion of its humanitarian assistance
work, the drugmaker said its Prevenar 13 shot, which protects babies
and children against pneumonia and other diseases, would be offered
in a new multi-dose vial at the lowest prevailing global price,
currently $3.10 per dose.
"In addition, given the acute need for aid on the ground, Pfizer
will donate all sales proceeds for the first year of this program to
humanitarian groups undertaking the difficult work of reaching
vulnerable populations in emergency settings," the company said in a
statement.
The move follows a similar one by the British drugmaker
GlaxoSmithKline, which said in September it would cut the price of
its pneumococcal vaccine, Synflorix, to $3.05 when it is used in
humanitarian crises.
The World Health Organization said last month it was seeking to
establish an emergency vaccine supply system aimed at getting vital
shots to vulnerable people in crises such as wars or natural
disasters.
(Editing by Greg Mahlich)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
|
